IBS patients commonly have NLRP3 expression disorder, rising IL-1β and caspase-1 expressions, and intestinal flora disturbance that further aggravate intestinal inflammation, indicating that NLRP3 dominantly participates in regulation of intestinal flora and maintenance of intestinal homeostasis [55]. The gene discussed is NLRP3; the disease is irritable bowel syndrome.